Cel-Sci financials
$1.79+5.29%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q3 '26 Jun 30 | Q2 '26 Mar 31 | Q1 '26 Dec 31 | Q4 '25 Sep 30 | Q3 '25 Jun 30 | Q2 '25 Mar 31 | Q1 '25 Dec 31 | Q4 '24 Sep 30 | Q3 '24 Jun 30 | Q2 '24 Mar 31 | Q1 '24 Dec 31 | Q4 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$5.6M | -$5.3M | -$5.4M | -$6.0M | -$5.5M | -$6.4M | -$6.9M | -$6.1M | -$6.7M | -$7.1M | -$6.5M | -$7.5M |
| Net income | -$5.7M | -$5.5M | -$5.5M | -$6.1M | -$5.7M | -$6.6M | -$7.1M | -$6.1M | -$7.5M | -$7.2M | -$6.7M | -$7.6M |
| Net margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-0.47 | $-0.67 | $-0.68 | $-0.86 | $-1.36 | $-2.33 | $-3.25 | $-1.61 | $-4.18 | $-4.20 | $-4.20 | $-4.91 |
| EBITDA | -$4.6M | -$4.4M | -$4.4M | -$5.1M | -$4.5M | -$5.4M | -$5.9M | -$5.1M | -$5.7M | -$6.1M | -$5.5M | -$6.5M |
| Operating cash flow | -$4.0M | -$4.0M | -$4.0M | -$4.7M | -$3.9M | -$4.4M | -$4.1M | -$4.8M | -$4.6M | -$4.5M | -$4.9M | -$5.0M |
| Free cash flow | -$4.0M | -$4.0M | -$4.0M | -$4.7M | -$3.9M | -$4.4M | -$4.2M | -$4.8M | -$4.6M | -$4.5M | -$4.9M | -$5.0M |
| Diluted shares | 12.1M | 8.1M | 8.0M | 7.1M | 4.2M | 2.8M | 2.2M | 3.8M | 1.8M | 1.7M | 1.6M | 1.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.5M | $1.9M | $6.3M | $11.0M | $1.8M | $1.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $6.3M | $6.8M | $7.4M | $8.0M | $8.5M | $9.0M |
| Total assets | $21.4M | $17.7M | $22.9M | $28.2M | $20.3M | $21.8M |
| Total liabilities | $10.4M | $10.8M | $11.8M | $12.2M | $13.3M | $13.8M |
| Shareholders' equity | $11.0M | $6.9M | $11.1M | $16.0M | $7.0M | $8.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology